---
figid: PMC10216951__cells-12-01373-g004
pmcid: PMC10216951
image_filename: PMC10216951__cells-12-01373-g004.jpg
figure_link: /pmc/articles/PMC10216951/figure/F4/
number: Figure 4
figure_title: 'IPA-predicted activation of the canonical pathway Superpathway of Inositol
  Compounds in the heart tissues of ZDF-F ats treated with NP-6A4IPA-predicted Z score:
  2.'
caption: 'IPA-predicted activation of the canonical pathway Superpathway of Inositol
  Compounds in the heart tissues of ZDF-F ats treated with NP-6A4IPA-predicted Z score:
  2.234. The orange color indicates the positive Z score and activation of the pathway'
article_title: Cardiovascular Protective Effects of NP-6A4, a Drug with the FDA Designation
  for Pediatric Cardiomyopathy, in Female Rats with Obesity and Pre-Diabetes
citation: Anthony M. Belenchia, et al. Cells. 2023 May;12(10).
year: '2023'
pub_date: 2023-5-
epub_date: 2023-5-12
doi: 10.3390/cells12101373
journal_title: Cells
journa_nlm_ta: Cells
publisher_name: MDPI
keywords:
- cardiovascular disease (CVD)
- body mass index (BMI)
- Angiotensin II receptor AT2 (AT2R)
- Zucker diabetic fatty-female (ZDF-F)
- Zucker diabetic fatty-male (ZDF-M)
- Zucker lean-female (ZL-F)
- Zucker lean-male (ZL-M)
- obesity
---
